Boone Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History

Boone Capital Management LLC

  • $386 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$36.25 - $43.75 $1.48 Million - $1.79 Million
-40,943 Reduced 14.05%
250,460 $9.77 Billion
Q1 2024

May 15, 2024
BUY
$42.66 - $50.04 $1.53 Million - $1.8 Million
35,971 Added 14.08%
291,403 $12.5 Billion
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $7.33 Million - $11.9 Million
255,432 New
255,432 $11.8 Billion

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Boone Capital Management LLC Portfolio

Follow Boone Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boone Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boone Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email